학술논문

9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Document Type
article
Author
Warren, HelenDudbridge, FrankFletcher, OliviaOrr, NickJohnson, NicholaHopper, John LApicella, CarmelSouthey, Melissa CMahmoodi, MaryamSchmidt, Marjanka KBroeks, AnnegienCornelissen, StenBraaf, Linda MMuir, Kenneth RLophatananon, ArtitayaChaiwerawattana, ArkomWiangnon, SuraponFasching, Peter ABeckmann, Matthias WEkici, Arif BSchulz-Wendtland, RuedigerSawyer, Elinor JTomlinson, IanKerin, MichaelBurwinkel, BarbaraMarme, FrederikSchneeweiss, AndreasSohn, ChristofGuénel, PascalTruong, ThérèseLaurent-Puig, PierreMulot, ClaireBojesen, Stig ENielsen, Sune FFlyger, HenrikNordestgaard, Børge GMilne, Roger LBenítez, JavierArias-Pérez, José-IgnacioZamora, M PilarAnton-Culver, HodaZiogas, ArgyriosBernstein, LeslieDur, Christina ClarkeBrenner, HermannMüller, HeikoArndt, VolkerLangheinz, AnneMeindl, AlfonsGolatta, MichaelBartram, Claus RSchmutzler, Rita KBrauch, HiltrudJustenhoven, ChristinaBrüning, ThomasNetwork, for The GENICAChang-Claude, JennyWang-Gohrke, ShanEilber, UrsulaDörk, ThiloSchürmann, PeterBremer, MichaelHillemanns, PeterNevanlinna, HeliMuranen, Taru AAittomäki, KristiinaBlomqvist, CarlBogdanova, NataliaAntonenkova, NataliaRogov, YuriyBermisheva, MarinaProkofyeva, DaryaZinnatullina, GuzelKhusnutdinova, ElzaLindblom, AnnikaMargolin, SaraMannermaa, ArtoKosma, Veli-MattiHartikainen, Jaana MKataja, VesaChenevix-Trench, GeorgiaBeesley, JonathanChen, XiaoqingInvestigators, for kConFabGroup, Australian Ovarian Cancer StudyLambrechts, DietherSmeets, AnnParidaens, RobertWeltens, CarolineFlesch-Janys, DieterBuck, KatharinaBehrens, SabinePeterlongo, PaoloBernard, LorisManoukian, SiranoushRadice, PaoloCouch, Fergus JVachon, CelineWang, XianshuOlson, Janet
Source
Cancer Epidemiology Biomarkers & Prevention. 21(10)
Subject
Health Services and Systems
Biomedical and Clinical Sciences
Health Sciences
Oncology and Carcinogenesis
Genetics
Human Genome
Aging
Breast Cancer
Clinical Research
Cancer
2.1 Biological and endogenous factors
Aetiology
Aged
Breast Neoplasms
Case-Control Studies
Chromosome Mapping
Chromosomes
Human
Pair 9
Female
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Middle Aged
Polymorphism
Single Nucleotide
Receptors
Estrogen
Receptors
Progesterone
GENICA Network
kConFab Investigators
Australian Ovarian Cancer Study Group
Medical and Health Sciences
Epidemiology
Biomedical and clinical sciences
Health sciences
Language
Abstract
BackgroundOur recent genome-wide association study identified a novel breast cancer susceptibility locus at 9q31.2 (rs865686).MethodsTo further investigate the rs865686-breast cancer association, we conducted a replication study within the Breast Cancer Association Consortium, which comprises 37 case-control studies (48,394 cases, 50,836 controls).ResultsThis replication study provides additional strong evidence of an inverse association between rs865686 and breast cancer risk [study-adjusted per G-allele OR, 0.90; 95% confidence interval (CI), 0.88; 0.91, P = 2.01 × 10(-29)] among women of European ancestry. There were ethnic differences in the estimated minor (G)-allele frequency among controls [0.09, 0.30, and 0.38 among, respectively, Asians, Eastern Europeans, and other Europeans; P for heterogeneity (P(het)) = 1.3 × 10(-143)], but no evidence of ethnic differences in per allele OR (P(het) = 0.43). rs865686 was associated with estrogen receptor-positive (ER(+)) disease (per G-allele OR, 0.89; 95% CI, 0.86-0.91; P = 3.13 × 10(-22)) but less strongly, if at all, with ER-negative (ER(-)) disease (OR, 0.98; 95% CI, 0.94-1.02; P = 0.26; P(het) = 1.16 × 10(-6)), with no evidence of independent heterogeneity by progesterone receptor or HER2 status. The strength of the breast cancer association decreased with increasing age at diagnosis, with case-only analysis showing a trend in the number of copies of the G allele with increasing age at diagnosis (P for linear trend = 0.0095), but only among women with ER(+) tumors.ConclusionsThis study is the first to show that rs865686 is a susceptibility marker for ER(+) breast cancer.ImpactThe findings further support the view that genetic susceptibility varies according to tumor subtype.